Skip to main content
. Author manuscript; available in PMC: 2016 Feb 8.
Published in final edited form as: Mult Scler. 2013 Jun 17;20(1):64–71. doi: 10.1177/1352458513492244

Figure 1.

Figure 1

Lesion and vein characteristics. A. Cumulative supratentorial lesion volume vs. time for all marmosets, two of which were immunized with recombinant human myelin oligodendrocyte glycoprotein (rhMOG) and two with human white matter homogenate (WMH). B. Supratentorial WM Total number of lesions, number of perivenular lesions, and number of perivenular lesions for which pre-existing veins could be detected on the baseline MRI. C. Vein topography. Number and location (deep vs. superficial) of veins involved in lesions. D. Number of lesions with deep cerebral veins (total and pre-existing). E. Number of lesions with superficial cerebral veins (total and pre-existing).